Active	Status	Sponsor type	Region	Phase	Filter
5 Active 3 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Marco, Fabiano Di
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia	Terminated	3	409	Europe, US, RoW	Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo	Dompé Farmaceutici S.p.A	Infectious Pneumonia, Severe COVID-19	09/24	09/24
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP	Active, not recruiting	3	1667	Europe, Canada, Japan, US, RoW	GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)	GlaxoSmithKline, Iqvia Pty Ltd	Asthma	10/25	10/25
PERSONAS, NCT06320119: Setting a PERSONalized Outcome in ASthma: the Study. A Patient Driven Outcome (PDO) Study	Recruiting	N/A	190	Europe	PDO Group	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Bronchial Asthma	01/25	09/25
NCT05826613: Respiratory Registry for Lung Health: a Prospective, Observational Study on Adult Patients With Asthma or COPD	Recruiting	N/A	500	Europe		Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	Chronic Obstructive Pulmonary Disease, Asthma	05/24	05/24
ULYSSES, NCT05634200: Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan	Recruiting	N/A	150	Europe	Bronchoscopy	University of Milan	Hemoptysis	10/24	10/25